- Home
- BNTX vs AVB Comparison
BNTX vs AVB Comparison
Compare BNTX & AVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- AVB
- Stock Information
- Founded
- BNTX 2008
- AVB 1978
- Country
- BNTX Germany
- AVB United States
- Employees
- BNTX N/A
- AVB N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- AVB Real Estate Investment Trusts
- Sector
- BNTX Health Care
- AVB Real Estate
- Exchange
- BNTX Nasdaq
- AVB Nasdaq
- Market Cap
- BNTX 28.3B
- AVB 31.7B
- IPO Year
- BNTX 2019
- AVB 1994
- Fundamental
- Price
- BNTX $108.78
- AVB $218.49
- Analyst Decision
- BNTX Strong Buy
- AVB Buy
- Analyst Count
- BNTX 16
- AVB 14
- Target Price
- BNTX $145.28
- AVB $238.14
- AVG Volume (30 Days)
- BNTX 811.0K
- AVB 625.5K
- Earning Date
- BNTX 05-05-2025
- AVB 04-24-2025
- Dividend Yield
- BNTX N/A
- AVB 3.20%
- EPS Growth
- BNTX N/A
- AVB 15.82
- EPS
- BNTX N/A
- AVB 7.60
- Revenue
- BNTX $3,390,698,192.00
- AVB $2,964,439,000.00
- Revenue This Year
- BNTX N/A
- AVB N/A
- Revenue Next Year
- BNTX N/A
- AVB $5.51
- P/E Ratio
- BNTX N/A
- AVB $28.76
- Revenue Growth
- BNTX N/A
- AVB 6.58
- 52 Week Low
- BNTX $76.53
- AVB $177.40
- 52 Week High
- BNTX $131.49
- AVB $239.29
- Technical
- Relative Strength Index (RSI)
- BNTX 42.81
- AVB 45.60
- Support Level
- BNTX $109.47
- AVB $216.96
- Resistance Level
- BNTX $115.10
- AVB $230.21
- Average True Range (ATR)
- BNTX 4.83
- AVB 4.07
- MACD
- BNTX -0.69
- AVB -0.22
- Stochastic Oscillator
- BNTX 17.49
- AVB 18.12
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 286 apartment communities with over 86,000 units and is developing 19 additional properties with over 6,800 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington D.C., California, and the Pacific Northwest.